Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StockTrans, Inc. was a prominent independent stock transfer agent and registrar that provided comprehensive shareholder services to publicly traded companies, with a significant client base in the biotechnology and life sciences sectors. Founded in 1974 and headquartered in Ardmore, Pennsylvania, the firm specialized in serving micro-cap and small-cap issuers, managing shareholder records, dividend disbursements, and proxy meeting logistics. In 2010, StockTrans was acquired by American Stock Transfer & Trust Company (AST), which integrated its operations into a larger global platform. While not a healthcare developer itself, StockTrans is frequently associated with the biotech industry due to its historical role as the transfer agent for numerous emerging pharmaceutical and medical technology companies during their early public stages.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StockTrans.